Brief: GT Biopharma Transfers Trike Manufacturing To Cytovance Biologics
18/02/2021 13:35
Feb 18 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA TRANSFERS TRIKE™ MANUFACTURING TO CYTOVANCE
BIOLOGICS IN PREPARATION FOR EXPANDED AND MULTIPLE LIQUID AND
SOLID TUMOR CLINICAL TRIALS
* GT BIOPHARMA INC - EXPANDED MANUFACTURING CAPABILITY
POSITIONS
CO TO INITIATE PROCESS OF ADDITIONAL CLINICAL TRIALS EXPECTED IN
EARLY 2022
Source text for Eikon: ID:nPn5T2d41a
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))